Literature DB >> 13064265

Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster.

T H WELLER.   

Abstract

Keywords:  CHICKENPOX; HERPES ZOSTER

Mesh:

Year:  1953        PMID: 13064265     DOI: 10.3181/00379727-83-20354

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  69 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  INFECTIVE AGENTS AND MULTIPLE SCLEROSIS.

Authors:  C A ROSS; J A LENMAN; C RUTTER
Journal:  Br Med J       Date:  1965-01-23

4.  [VIROLOGICAL AND SEROLOGICAL STUDIES IN HERPES ZOSTER].

Authors:  J SOELTZ-SZOETS
Journal:  Arch Klin Exp Dermatol       Date:  1964-07-03

5.  [STUDIES WITH THE VARICELLA-HERPES ZOSTER VIRUS].

Authors:  J SOELTZ-SZOETS
Journal:  Arch Klin Exp Dermatol       Date:  1965-03-08

6.  Giant cell pneumonia and measles: an analytical review.

Authors:  D T JANIGAN
Journal:  Can Med Assoc J       Date:  1961-09-23       Impact factor: 8.262

7.  Chickenpox and herpes zoster. III. Tissue culture studies.

Authors:  D TAYLOR-ROBINSON
Journal:  Br J Exp Pathol       Date:  1959-12

8.  The soluble antigens of varicella-zoster virus produced in tissue culture.

Authors:  A E CAUNT; C J RONDLE; A W DOWNIE
Journal:  J Hyg (Lond)       Date:  1961-06

9.  Herpes zoster ophthalmicus in children.

Authors:  S M TUCKER
Journal:  Arch Dis Child       Date:  1958-10       Impact factor: 3.791

10.  Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.

Authors:  P Gupta; R Balachandran; M Ho; A Enrico; C Rinaldo
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.